MADRID+90 study on factors associated with longevity: Study design and preliminary data

PLoS One. 2021 May 17;16(5):e0251796. doi: 10.1371/journal.pone.0251796. eCollection 2021.

Abstract

The progressive aging of the population represents a challenge for society. In particular, a strong increase in the number of people over 90 is expected in the next two decades. As this phenomenon will lead to an increase in illness and age-related dependency, the study of long-lived people represents an opportunity to explore which lifestyle factors are associated with healthy aging and which with the emergence of age-related diseases, especially Alzheimer's type dementia. The project "Factors associated with healthy and pathologically aging in a sample of elderly people over 90 in the city of Madrid" (MADRID+90) brings together a multidisciplinary research team in neurodegenerative diseases that includes experts in epidemiology, neurology, neuropsychology, neuroimaging and computational neuroscience. In the first phase of the project, a stratified random sampling was carried out according to the census of the city of Madrid followed by a survey conducted on 191 people aged 90 and over. This survey gathered information on demographics, clinical data, lifestyles and cognitive status. Here, the main results of that survey are showed. The second phase of the project aims to characterize individual trajectories in the course of either healthy and pathological aging, from a group of 50 subjects over 90 who will undergo a comprehensive clinical examination comprised of neurological and cognitive testing, MRI and EEG. The ultimate goal of the project is to characterize the biophysical and clinical profiles of a population that tends to receive little attention in the literature. A better understanding of the rapidly increasing group of nonagenarians will also help to design new policies that minimize the impact and future social and economic consequences of rapidly aging societies.

Publication types

  • Multicenter Study
  • Observational Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / physiopathology
  • Electroencephalography*
  • Female
  • Follow-Up Studies
  • Health Status*
  • Humans
  • Longevity*
  • Magnetic Resonance Imaging*
  • Male
  • Preliminary Data

Grants and funding

This study was supported and funded by the Multidisciplinary Research Program of the Fundación General de la Universidad de Salamanca (FGUSAL)-CENIE within the Interreg V-A Program, Spain - Portugal, (POCTEP), 2014-2020 to MAFB (Grant 0348_CIE_6 by Fondos FEDER UE).